FDA kicks Regeneron’s latest Eylea application to the curb, but they’re not sweating it
Regeneron $REGN says the FDA has rejected their application to sell a pre-filled syringe with Eylea, delaying a supplemental add-on that the biotech wants to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
